Protara Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Protara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Protara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $4.51M, a 18.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.51M -$1.05M -18.9% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $4.77M -$1.04M -17.9% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.02M -$1.03M -17% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $5.26M -$1.01M -16.1% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $5.57M -$939K -14.4% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $5.81M -$924K -13.7% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $6.04M -$909K -13.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $6.28M -$894K -12.5% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $6.51M -$907K -12.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $6.73M -$917K -12% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $6.95M +$5.92M +570% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.17M +$6.11M +577% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $7.41M Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $7.65M +$7.26M +1891% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.04M +$645K +165% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.06M Dec 31, 2020 10-K 2022-03-09
Q2 2020 $384K +$316K +465% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $392K +$257K +190% Mar 31, 2020 10-Q 2020-05-13
Q2 2019 $68K Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $135K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.